SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma
J Nucl Med
.
2024 Feb 8;65(6):988-989.
doi: 10.2967/jnumed.123.267124.
Online ahead of print.
Authors
Malte Kircher
1
,
Adriana Amerein
2
,
Mareike Augustin
3
,
Nic G Reitsam
4
,
Johanna S Enke
2
,
Marianne Patt
2
,
Georgine Wienand
2
,
Ralph A Bundschuh
2
,
Christian H Pfob
2
,
Constantin Lapa
2
,
Alexander Dierks
2
Affiliations
1
Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
[email protected]
.
2
Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
3
Department of Dermatology, Faculty of Medicine, University of Augsburg, Augsburg, Germany; and.
4
Department of Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
PMID:
38331456
PMCID:
PMC11149596
DOI:
10.2967/jnumed.123.267124
No abstract available